OpenAlex
PricingAboutJobs
Log inGet started
Work

Down-regulation of hepcidin resulting from long-term treatment with an anti–IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease

HTML

Year: 2010
Type: article
Source: Blood
DOI: 10.1182/blood-2010-03-271791
Authors: Soken-Nakazawa J. Song, Naohisa Tomosugi, Hiroshi Kawabata, Takayuki Ishikawa, Teppei Nishikawa, Kazuyuki Yoshizaki
Institutions: The University of Osaka, Kanazawa Medical University, Kyoto University
Language: English

Topic: Iron Metabolism and Disorders
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: multicentric Castleman disease, hepcidin, interleukin-6, tocilizumab, anemia of chronic disease, IL-6 receptor inhibition, iron metabolism, hepatoma cells, lymphoproliferative disorders
SDG: Good health and well-being

Open Access status: closed

Funder: Japan Society for the Promotion of Science
Award: Regulatory mechanisms of hepcidin, the central regulator of body iron homeostasis
OpenAlex ID: W1979482280
FWCI: 10.53
Cites: 37
Cited by: 246
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security